Kosmac, K., Bantug, G. R., Pernjak Pugel, E., Cekinović, Đ., Jonjić, S. i Britt, W. J. (2013). Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens, 9. (3). doi: 10.1371/journal.ppat.1003200
Kosmac, Kate, et al. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens, vol. 9, br. 3, 2013. https://doi.org/10.1371/journal.ppat.1003200
Kosmac, Kate, Glenn Robert Bantug, Ester Pernjak Pugel, Đurđica Cekinović, Stipan Jonjić i William J. Britt. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens 9, br. 3 (2013). https://doi.org/10.1371/journal.ppat.1003200
Kosmac, K., et al. (2013) 'Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development', PLoS Pathogens, 9(3). doi: 10.1371/journal.ppat.1003200
Kosmac K, Bantug GR, Pernjak Pugel E, Cekinović Đ, Jonjić S, Britt WJ. Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens [Internet]. 07.03.2013. [pristupljeno 04.12.2024.];9(3). doi: 10.1371/journal.ppat.1003200
K. Kosmac, G. R. Bantug, E. Pernjak Pugel, Đ. Cekinović, S. Jonjić i W. J. Britt, "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development", PLoS Pathogens, vol. 9, br. 3, Ožujak 2013. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:792777. [Citirano: 04.12.2024.]